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ABSTRACT 
Glycosaminoglycans (GAGs) are linear polysaccharide chains which, with the 
exception of Hyaluronan, are covalently linked to a core protein to assemble 
a more complex molecule called Proteoglycan (PG). GAGs/PGs are involved in 
several physiological and pathological processes being among the major 
constituents of the Extracellular Matrix. Regarding their role in the Peripheral 
Nervous System (PNS), GAGs/Proteoglycans-mediated interactions 
participate in proliferation, synaptogenesis, neural plasticity and 
regeneration. Generally PNS nerve fibers have a remarkable ability to 
regenerate, leading to an almost complete recovery of normal function and 
this process is governed by glial cells known as Schwann cells, by their 
unusual capacity to metamorphose into cells driving the healing process.  
However, posttraumatic nerve repair continues to be a major challenge in 
restorative medicine and micro-surgery. Although progress has been made in 
surgical techniques, functional recovery after a severe lesion of a major nerve 
trunk is often incomplete and unsatisfactory.  
In this  PhD project I discuss the role of glycosamynoglycans in promoting the 
regeneration processes in Schwann Cells seeded in electrospun scaffolds 
functionalized with purified GAGs from porcine aorta tissue. 
Results show that Schwann cells seeded in Polycaprolactone (PCL) scaffolds 
increase proliferation and metabolic activities per time points and the levels 
of protein expression vary in cells seeded in functionalized scaffolds. 
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GAGs are large linear polysaccharides consisting in repeating disaccharide 
units each composed of an amino sugar [N-acetylglucosamine (GlcNAc), or N-
acetylgalactosamine (GalNAc)] and an uronic acid [glucuronic acid (GlcA) or 
iduronic acid (IdoA)] or galactose (1-3). 
Based on the amino sugar of the disaccharide units, GAGs can be classified 
into two groups: galactosaminoglycans and glucosaminoglycans. 
Galactosaminoglycans include chondroitin sulfate (CS), dermatan sulfate (DS), 
whereas glucosaminoglycans consist of hyaluronic acid (HA, also called 
hyaluronan), heparan sulfate (HS), Heparin (HE), and keratan sulfate (KS). 
The constituent disaccharides are GlcA and GlcNAc for HA, GlcA and GalNAc 
for CS, IdoA and GalNAc for DS, GlcA or IdoA and GlcNAc for HS, and 
galactose and GlcNAc for KS (Fig. 1). 
 
Figure 1. Glycosaminoglycans disaccharide units. 
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DS is also known as CS-B because it is a modified form of CS, whereas Heparin 
is a special form of HS present in mast cells. Heparin is made exclusively as 
serglycin proteoglycan, is highly sulfated, and contains more IdoA residues 
than does HS. HA lacks of sulfate groups and is not attached to a core 
protein, whereas other GAGs contain sulfate groups at various positions and 
are  always attached to a core protein.  
Proteoglycans represent a large group of glycoproteins that are ubiquitously 
present in the ECM or on the cell surface of virtually all animal cells (Fig. 2) (2, 
4-6).  
 
Figure 2. The proteoglycans consist of a core protein and covalently attached 
glycosaminoglycan (GAG)s. They can also be categorized into the ECM type and the 
membrane-bound type. Brown, red, and blue lines denote core proteins, CS, and HS, 
respectively.  
 
They consist of core proteins and one or more covalently attached GAG 
chains. Some proteoglycans contain only one GAG chain, whereas others 
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have more than 100 GAG chains. The attachment site is a Ser residue in the 
core protein, and generally contains the -Ser-Gly-X-Gly- sequence, in which X 
can be any amino acid other than proline. Most proteoglycans contain O- and 
N-glycans in addition to GAGs, but GAGs are much larger and more abundant 
than other types of glycans, conferring the characteristic chemical properties 
of proteoglycans. Proteoglycans are named after their core proteins (for 
example, aggrecan, versican, glypican, and syndecan) and after their GAG 
chains (for example, CSPG and HSPG). They are also classified into ECM and 
membrane-bound types (Fig. 2).  
Proteoglycans show a wide range of biological activities through their 
interaction with various molecules (2, 3, 5, 6). For example, CSPGs in cartilage 
interact with many ECM proteins (collagens, elastins, fibronectin, laminins, 
tenascins, and so forth), thereby providing the physical properties of 
cartilage, strength and elasticity, owing to their capacity to anchor fibrous 
proteins and to bind water and hydrated matrices. In addition to such 
relatively static roles, accumulating evidence has revealed that proteoglycans 
dynamically regulate intercellular signaling. Proteoglycans in the ECM bind 
morphogens, growth factors, and axon guidance molecules and protect them 
from proteolytic degradation. Proteoglycans thus act as a reservoir of 
signaling molecules and release them upon selective degradation of the ECM 
components, although the molecular mechanisms remain to be elucidated. 
Proteoglycans play critical roles in the formation of morphogen gradients, 
which are essential for development. Membrane-bound proteoglycans can 
act as receptors or co-receptors for signaling molecules and are essential for 
cell differentiation, growth, migration, and axon guidance. These functions of 
proteoglycans depend on the presence of GAGs and their diverse structures 
because the molecular interaction with signaling molecules is mediated by 
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GAGs.  
Ones of the most studied proteoglycan families are Syndecans. 
Syndecans are a gene family of four transmembrane heparan sulfate 
proteoglycans that bind, via their HS chains, various components of the 
cellular microenvironment.  
Syndecan-1, the most extensively studied integral membrane HSPG, is 
abundant in epithelial cells and embryonic mesenchyme and can bind, via its 
heparansulfate chains, a wide variety of matrix molecules and growth factors 
such as collagens I, III, V, fibronectin, and fibroblast growth factors (FGF-2) (7-
11). Furthermore, the proteoglycan core protein appears to associate 
intracellularly with F-actin, thus bridging the extracellular matrix with the 
cytoskeleton. 
Syndecan-1 expression is regulated at multiple levels. Transcriptional control 
has been observed in vivo during development at sites of epithelial-
mesenchymal interactions (12). In addition, syndecan-1 expression is 
regulated posttranscriptionally (12-14) and posttranslationally (15). These 
multiple levels of regulation precisely control the expression of syndecan-1 
during various developmental processes, beginning as early as the four-cell 
stage (16) as well as during cutaneous wound repair (17). The shedding of the 
extracellular domain of syndecan-1 from the cell surface as an intact 
proteoglycan provides an additional potential control. 
Syndecan-1 mRNA is abundant in fibroblastic and epithelial cells, being 
especially high in keratinocytes, but very low in endothelial and neural cells. 
This fits with its expression in adult tissues, where syndecan-1 mRNA is most 
abundant in tissues rich in epithelial cells and fibroblasts, such as skin, liver, 
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kidney, and lung, less abundant in brain and small intestine, and 
undetectable in cardiac and skeletal muscles (18).  
Syndecan-2 is the major form in mesenchymal cells, and is present in neural 
tissue along with syndecan-3.  
More than one syndecan is commonly present in a single cell type, but 
syndecan-4 is distinct in that it is present in a wide range of cells that form 
stable adhesions. Syndecan-4 is also the only mammalian family member that 
is consistently present in focal adhesions in colocalization with integrin, a 
transmembrane receptor involved in cell-cell and cell-matrix interactions 
(19). 
Syndecan-4 mRNA is abundant in both epithelial and fibroblastic cells with 
intermediate levels in neural cells and lower amounts in endothelial cells. In 
tissues, it is abundant in liver and kidney, intermediate in amount in brain 
and lung, and low in heart, skeletal muscle, skin, and small intestine.  
 
 
1. 2 PERIPHERAL NERVOUSE SYSTEM 
The Peripheral Nervous System (PNS) is one of the two major components of 
the body's nervous system. In conjunction with the Central Nervous System 
(CNS), the PNS coordinates action and responses by sending signals from one 
part of the body to another. The CNS includes the brain, brain stem, and 
spinal cord, while the PNS includes all other sensory neurons, clusters of 




Glycosaminoglycans purification and caracterization: from pathophysiology to tissue engineering. 
PhD thesis in PhD school in Life Sciences and Biotechnologies, 
Biochemistry, Physiology and Molecular Biology curriculum 
 Università degli studi di Sassari 8 
1. 2. 1 ANATOMY AND PHYSYOLOGY 
Depending on the composition of the fibers peripheral nerves are classified in 
three main categories: sensory, motor and mixed nerves (20). 
Sensory nerve fibers originate from pseudounipolar neurons located in the 
sensory ganglia (except VII cranial nerve and the mesencephalic root of the V 
cranial nerve). 
On the other hand, motor nerve fibers originate from somatic and autonomic 
motor neurons located in the CNS. 
While somatic or motor fibers directly reach the target skeletal muscle fibers, 
autonomic motor fibers create synapses in an ortho- or parasympathetic 
ganglion where the second order autonomic neuron is located, and the axon 
of which eventually reaches the target visceral organs (20). 
 
Generally, the peripheral nerve is represented by a nerve fiber made by 
axons and the surrounding Schwann cells, but in reality nerves are composed 
of more than just nervous tissue. They have connective tissues implicated in 
their structure, as well as blood vessels supplying the tissues with 
nourishment. The outer surface of a nerve is a surrounding layer of fibrous 
connective tissue called epineurium. Within the nerve, axons are further 
bundled into fascicles, which are each surrounded by their own layer of 
fibrous connective tissue called perineurium. Finally, individual axons are 
surrounded by loose connective tissue called endoneurium. These three 
layers are similar to the connective tissue sheaths for muscles. Nerves are 
associated with the region of the CNS to which they are connected, either as 
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cranial nerves connected to the brain or spinal nerves connected to the 
spinal cord. 
 
Figure 3. Structural components of peripheral nerves  
Within the endoneurium, all axons are intimately associated with Schwann 
cells. As shown in Figure 3, the myelin of each myelinated axon is formed 
from the plasma membrane of a Schwann cell wrapped tightly multiple times 
around the axon. Thus, a single Schwann cell envelops a single myelinated 
axon, forming an internode. Along a myelinated axon, the points of  
separation between myelinating Schwann cells in series are called nodes of 
Ranvier. Unmyelinated axons are enveloped by Schwann cell cytoplasm and 
plasma membrane but do not have multiple wrappings of Schwann cell 
plasma membrane. A single Schwann cell may envelop several unmyelinated 
axons. The Schwann cell of each myelinated axon or group of unmyelinated 
axons is surrounded by a basal lamina of type IV collagen, fibronectin, 
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laminin, and heparan sulfate proteoglycan (21). Between the axons this is a 
loose connective tissue constituting of type I and type II collagen fibrils in 
longitudinal orientation, fibroblasts, a few mast cells and macrophages, and 
endoneurial fluid. 
The perineurium (Fig. 3) is formed by up to 15 layers of flat perineurial cells 
interspersed with layers of type I and type II collagen fibrils and elastic fibers 
in circumferential, oblique, and longitudinal orientations (22). Each layer of 
perineurial cells has a nearly complete basal lamina (21), and the very 
organized basal lamina of the innermost layer contains laminin, as well as 
heparan sulfate proteoglycan and fibronectin (23). Adjacent perineurial cells 
are linked by tight junctions, and the most internal perineurial cells form a 
perineurial diffusion barrier that functions with the blood-nerve barrier in 
controlling the endoneurial environment (24, 25). These layers of collagen 
and perineurial cells provide mechanical strength, making the perineurium 
the primary load bearing portion of the nerve (26-28).  
Nerve fascicles are held together and surrounded by a connective tissue 
layer, termed the epineurium (Fig. 3). If the nerve contains more than one 
fascicle, the epineurium may be divided into epifascicular epineurium 
surrounding the entire nerve and interfascicular epineurium separating nerve 
fascicles. The epineurial layer includes bundles of type I and type III collagen 
fibrils and elastic fibers, as well as fibroblasts, mast cells, and fat cells. The 
number of fascicles and the proportion of epineurial connective tissue are 
variable between nerves and along the length of a single nerve (29). Axons do 
not remain in the same fascicle throughout their length (30). The interchange 
of axons between fascicles may help to minimize functional deficits following 
partial injury to the nerve (29), but also may result in a wide distribution of 
macrophages cleaning up the debris from axons undergoing Wallerian 
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degeneration after injury. Interfascicular epineurium is loosely attached to 
the perineurium, allowing for sliding of one fascicle independently of an 
adjacent fascicle (31). There is abundant epineurial connective tissue in 
nerves that contain many fascicles, and the connective tissue facilitates the 
dispersion of compressive forces (32). 
The outermost tissue of the epineurium is attached to perineural fascial 
components of the connective tissue surrounding the epineurium (31), and 
the density and strength of the attachments differ along the length of a 
nerve. The perineural  loose connective tissue may contain a significant 
amount of adipose tissue, which serves to protect the nerve at sites of 
recurrent compression and facilitates transverse and longitudinal gliding of 
the nerve within the nerve bed. The epineurium is more tightly adherent to 
the surrounding connective tissues where vessels enter or exit the nerve and 
where the nerve branches (31). Additionally, there are points at which a 
nerve may be firmly attached to an anatomical landmark, such as the 
attachment of the common peroneal nerve near the neck of the fibula.  
The blood supply to nerves is provided by coiled segmental arteries that 
enter the epineurium periodically along the length of the nerve and form the 
vasa nervorum. Arteries divide into epineurial arterioles that form an 
anastomotic network running primarily longitudinally within the epifascicular 
epineurium and the interfascicular epineurium. Epineurial arterioles are 
supplied with a perivascular plexus of serotoninergic, adrenergic, and 
peptidergic nerves (33, 34). Perforating arterioles cross the perineurium at 
oblique angles and carry a short sleeve of perineurial cells into the fascicle 
(21, 35). Perineurial arterioles have poorly developed smooth muscle and 
thus have limited ability to regulate intrafascicular blood flow (36). Within 
the endoneurium, arterioles immediately turn into large-diameter, 
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longitudinally oriented capillaries that allow blood flow in either direction 
(37). The endothelial cells of endoneurial capillaries are connected by tight 
junctions, thus forming the tight blood-nerve barrier (25). Venules return 
blood to the venous system. Of note, lymphatic capillaries are present only 
within the epineurium and there is no lymphatic drainage from the 
intrafascicular or endoneurial space .  
1. 2. 2 NERVE REGENERATION 
Trauma to peripheral nerve trunks may result in various extents of nerve 
fiber injury. The axonal fate is a critical factor in determining the extent, time 
course, and recovery following nerve injury.  
After a peripheral nerve sustains a traumatic injury, complex 
pathophysiologic changes, including morphologic and metabolic changes, 
occur at the injury site. These complex changes also occur in the nerve cell 
body, in the segments proximal and distal to the injury site, and in the distal 
endings of both muscle end-plates and sensory receptors. Changes in the 
nerve at the site of injury begin almost immediately. With crushing or 
transection of a nerve trunk, significant changes take place in normal 
morphology and tissue organization proximally and distally to the lesion (Fig. 
4).  
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Figure 4. Nerve regeneration phases 
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EFFECTS IN THE PROXIMAL NERVE SEGMENT  
Transection of an axon means amputation of a major part of the axoplasmic 
volume from the cell. It is therefore not surprising that such a traumatic 
event may lead not only to profound changes in cell body structure and 
function but also to cell death (38). These changes occur in both the dorsal 
root ganglia sensory neurons and in the motor neurons of the spinal cord 
anterior horn.  
Changes can be seen in the nerve cell body as early as several hours after the 
injury. The series of morphologic changes that ensue in the cell body after 
injury are known as chromatolysis, and they entail cell body and nucleolar 
swelling, and nuclear eccentricity. All of these changes involve an alteration 
of the metabolic machinery from being primarily concerned with transmitting 
nerve impulses to fabricating structural components for reconstruction of the 
injured nerve (39, 40). The neurons switch from a ‘‘signaling mode’’ to a 
‘‘growing mode’’ (41), and protein synthesis switches from neurotransmitter-
related substances to those required for axonal reconstruction (42, 43). 
Metabolic changes include altered synthesis of many neuropeptides (44) and 
changes in synthesis of cytoskeletal proteins (45, 46) and growth-associated 
proteins (47, 48). 
In the proximal segment, axons degenerate for some distance back from the 
site of injury, leaving the corresponding endoneurial tubes (the basal laminae 
of the Schwann cell) behind as empty cylinders. This retrograde degeneration 
may extend over one or several internodal segments, the length depending 
on the severity of the lesion.  
Within hours after injury, the axon in the proximal segment produces a great 
number of collateral and terminal sprouts that advance distally along the 
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tube on the inside of the basal lamina (49, 50). The terminal sprouts arise 
from the tip of the remaining axon. Within hours of axotomy, small 
axoplasmic outgrowths have been observed from axoplasmic tips (51). This 
first wave of sprouts is followed by a second wave, appearing within the first 
2 days (50, 52). Early sprouts can apparently degenerate before the definitive 
sprouting phase occurs. The time required for the definite sprouts to appear 
has been called the ‘‘initial delay’’ (53). A study on rat regenerating sciatic 
nerve (54) showed that sprouts have great variability in their behavior. There 
were ‘‘direct’’ projections (i.e., single sprouts crossing the gap), often 
traveling laterally in the interstump gap before entering a distal Schwann cell 
tube. ‘‘Arborizing’’ projections, in contrast, sampled 5–10 distal tubes from 
among more than 100 within their 50- to 100-mm spread. A single axon 
traveling within distal Schwann cell tubes continued to sprout  collaterals, 
suggesting that the process of sprouting is a natural concomitant of 
regeneration. Schwann cell tubes in the distal segment were sometimes 
reinnervated by sprouts from several different parent axons.  
Several researches show that Schwann cells play an important role in nerve 
regeneration at the site of injury. Schwann cells elaborate processes that 
include physical conduits that guide axons to their targets. The rate of axon 
regeneration is limited by the extension of these Schwann cell processes 
rather than by axonal growth (55). The regenerating units will initially lack 
myelin even when the parent axon is a myelinated fiber. With time, these 
unmyelinated fibers will become myelinated (56). 
To reach the distal segment, the advancing sprouts have to pass a critical 
area between the proximal and distal stumps of the cut nerve: the 
interstump zone. The final success of the nerve regeneration is, to a great 
extent, dependent on what happens at this level and in what way local 
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chemical and cellular reaction can influence the growth of sprouts toward 
their peripheral pathways.  
 
EFFECTS IN THE DISTAL NERVE SEGMENT  
After nerve transection, the distal segment undergoes a slow process of 
degeneration known as Wallerian degeneration. This process starts 
immediately after injury and involves myelin breakdown and proliferation of 
Schwann cells. Schwann cells and macrophages are recruited to the injury 
site, and over a period of 3–6 weeks they phagocytize all the myelin and 
cellular debris.  
Within hours after transection, the axon membrane fuses and seals the ends. 
Disintegration of the axons starts within the first days. The first stages of this 
process are characterized by a granular disintegration of axoplasmic 
microtubules and neurofilaments due to proteolysis (57-59).  
The loss of axon–Schwann cell contact is a signal that causes the Schwann cell 
proliferation. Schwann cells upregulate the synthesis of several types of 
neurotrophic factors as Nerve Growth Factor (NGF) (60, 61). In addition to 
NGF, Schwann cells also produce and present various neurotrophins to the 
outgrowing axons (62) and the glial growth factor neuregulin (63). 
Proliferating Schwann cells organize themselves into columns (named bands 
of Büngner) and the regenerating axons associate with them by growing 
distally between their basal membranes.  
The advancement of regenerating axons in the distal segment is promoted by 
neurite outgrowth-promoting factors, such as laminin and fibronectin (64-
66). A number of cell adhesion molecules such as Neural cell adhesion 
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molecule (N-CAM), L1 cell adhesion molecule, the myelin-associated 
glycoprotein, and tumor-associated glycoprotein (TAG)-1, also play an 
important role (67, 68). In the distal segment, axon sprouts (which do not 
take an extraneural course) either approach a Schwann cell column or may 
grow at random into the connective tissue of the nerve. The Schwann cell 
columns are invaded by axon sprouts arising from parent axons in the 
proximal segment.  
Since an excess number of sprouts invade the distal Schwann cell columns 
(69, 70), the initial number of axons present in the distal nerve segment may 
considerably exceed the number in the same nerve proximal to the lesion 
(71). With time, some of the regenerated axons, which have reached 
appropriate distal targets, enlarge, mature, and regain a close-to-normal 
diameter (70) as result of a trophic supply from the target organs. Other 
branches that do not reach the target are pruned away and disappear. After a 
few months of nerve regeneration, we will see a reorganization of the nerve 
trunk into a large number of miniature compartments, each surrounded by a 
new perineurium: a process in which the distal stump of a divided nerve 
became separated into numerous nerve bundles, or ‘‘minifascicles,’’ to 
replace the original large fascicle. This phenomenon is known as 
‘‘compartmentation’’ (72). Initially, it occurs also in the proximal stump of a 
cut nerve and in the gap between the two ends as the axons advance. The 
stimulus to compartmentation is probably a disturbance of the endoneurial 
environment resulting from damage to the perineurium. The formation of 
numerous miniature fascicles expresses the need for restitution of the 
normal endoneurium environment around the nerve fibers as quickly as 
possible by restoring the perineurial barrier (73).  
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Prolonged denervation of the distal segment results in a progressive increase 
in collagen content and extensive changes in the distribution of collagen 
types have been observed in the endoneurium and perineurium (74). 
Collagen production in the endoneurium may result from fibroblast activity 
but it may also be a result of Schwann cell activity (75, 76).  
When assessing the rate of axonal outgrowth in experimental animals, 
several factors seem to play a role, such as the nature of the lesion, the 
species and the method of assessment. The quality of outgrowth obtained 
after transection and suture is always worse than that obtained after a crush 
injury. The regeneration rate in rat and rabbit nerves falls within the range of 
2.0–3.5 mm/day after transection and repair and 3.0–4.4 mm/day after a 
crush lesion (73).  
 
1. 3 EXTRACELLULAR MATRIX COMPONENTS IN NERVE 
REGENERATION 
The ECM is a physiological integrative matrix of complex molecular nature, 
where axons and supportive cells are immersed. The ECM is a three-
dimensional network arranged in the intercellular space, which includes 
proteins and carbohydrates synthesized and secreted by the cells. It is 
present in the interstitial spaces of all tissues, playing important roles in cell 
migration, proliferation, and differentiation, and providing structural support 
and regulating intercellular communication. It contributes to mechanical 
tissue properties, allows the cells to form tissues, serving to cell 
communication, and forms paths where cells can move. In the peripheral 
nerve, the ECM is found in the basal lamina of Schwann cells and the 
endoneurium.  
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The basal lamina, produced by the Schwann cells, may be considered a layer 
of the ECM, mainly composed of collagen type IV, laminin, fibronectin, and 
nidogens (77-79). After injury, besides the degenerative process behold in 
the distal stump, basal lamina tubes remain as scaffolds where proliferative. 
The ECM is composed of a complex network of secreted proteins, glyco- 
proteins, proteoglycans, and non-proteoglycan polysaccharides. The first 
group of components, the glycoproteins, can be classified into collagen and 
noncollagenous molecules.  
Collagens are a superfamily of trimeric molecules composed of three 
identical triple helical chains that define tissue structures (80, 81). Up to 26 
different types of collagens have been described, that are divided into 
different groups according to the structures they form. The main subfamilies 
are fibril-forming collagens (types I, II, III, V, XI), collagens banded-fibrils 
associated (IX, XVI, XIX, XXI, XXII), networking collagens (IV, VI, VIII, X), trans- 
membranous collagens (XIII, XXIII, XV), endostatin precursor collagens (XV, 
XVII), and other collagens. However, it is interesting to highlight the 
importance of collagen types related to fibril formation (collagen type I) and 
the basement membrane (collagen type IV).  
Among the ECM noncollagenous molecules of glycoprotein origin, the most 
important are laminins and fibronectins.  
Laminins are high-molecular weight proteins of the ECM, participating in cell 
differentiation, migration, and adhesion activities. They are an active part of 
the natural scaffolding which structure the tissues. They are mainly found in 
the basal lamina. Laminins are heterotrimers of α, β, and γ chains, and 18 
different types have been described to date (82). The trimers are named 
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according to the composition of the different chain types, but usually it is the 
α chain that identifies the isoform. Secreted by Schwann cells, laminin-2 (α2, 
β1, γ1) and laminin 8 (α4, β1, γ1) are found in the peripheral nerves (83) 
whereas laminin 10 (α5, β1, γ1) can be detected in sensory end organs (84). 
Laminin is the adhesive component that gives the regenerative-promoting 
capability to basal lamina scaffolds after nerve injury (85) and has been 
shown to promote neuritogenesis in vitro (86).  
Fibronectin is a noncollagenous glycoproteins of the ECM (87). It forms a 
fibrillar matrix similar to collagen and mediates cell-binding. Fibronectin is a 
dimer existing in different isoforms because of alternative splicing 
generation. Totally, 12 isoforms for mice and 20 for humans have been 
described. At first, soluble fibronectin is produced by hepatocytes, being 
found in the blood plasma. The insoluble form is incorporated into the 
membrane of many cells. In the nervous system, it is synthesized and 
secreted by Schwann cells and fibroblasts (78, 88). The important relations 
that it maintains with collagen type IV and laminins and with fibril formation 
make fibronectin an interesting candidate for scaffolding in nerve 
regeneration (80).  
The ability of cells to interact with both laminins and fibronectins is mainly 
due to the expression of the cell adhesion molecule integrins in their 
membrane (89). Integrins are glycosilated heterodimers formed by α and β 
subunits. The integrin β1 subfamily is composed of integrins with a β1 
subunit, which bounds to actin cytoskeleton, and the a subunit, which 
determines the specificity to the ECM molecule adhesion. Thus, integrin α1, 
α3, α6, and α7 can interact with laminin, whereas integrin α5 interacts with 
fibronectin. Expression of integrins on the growth cone determines the ability 
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of the growing axon to interact with the ECM. Moreover, laminin and 
fibronectin have the characteristic of binding to other ECM components. For 
instance, laminin interacts with nidogens, agrin, perlecan, fibulin-1, heparin, 
and sulfatides (90, 91), whereas fibronectin binds to collagen, fibrin, and 
heparan sulfate proteoglycans (92).  
There are other noncollagenous glycoproteins of the ECM although they are 
probably not related to axonal regeneration after nerve injury. Nidogen-1 
(also called entactin) forms noncovalent unions with laminin and collagen 
type IV and may play its role as a promigratory factor for adult Schwann cells 
(93). On the other hand, vitronectin binds to collagen and 
glycosaminoglycans (GAGs) (heparin), acting as a regulatory molecule 
controlling cell adhesion (94).  
Fibrin is not associated with the mature tissue structure but it is a key factor 
in the repair strategy of the ECM components. It can form a provisional mesh 
after damage that will be later replaced by the mature components of the 
ECM secreted by invading cells. In the presence of thrombin, fibrinogen 
polymerizes into fibrin to form a dense meshwork of fibers (80, 95). In fact, 
formation of a fibrin cable between the two stumps when a gap nerve is 
repaired by a tube is needed to guarantee successful axonal regeneration.  
 
1. 4 TISSUE ENGINEERING 
Peripheral nerve injury is a large-scale problem annually affecting more than 
one million people worldwide. These injuries often result in painful 
neuropathies owing to reduction in motor function and sensory perception. 
Peripheral nerve injuries are common in both civil and military environments 
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and are primarily the result of transection injuries or burns, but may also 
arise from degenerative conditions (96, 97). Over relatively short nerve gaps, 
spontaneous natural regeneration may occur. However, over larger gaps, 
microsurgical repair is essential for nerve repair (98-100). 
Conventionally, autologous grafts are gold standards and have been used to 
treat neural defects (101-103).  
However, autografts have limitations that include short-age of nerves since it 
is taken from the patient. Moreover, there is a mismatch of donor-site nerve 
size with the recipient site, neuroma formation and lack of functional 
recovery (104, 105). Allogenic grafts, which are isolated from cadavers, are 
not limited by supply but suffer from host-graft immune rejection (106). To 
overcome immune rejection, several studies have been conducted to 
examine the potency of acellular nerve grafts (107, 108). However, as 
acellular nerve graft lacks viable cells, studies regarding nerve regeneration 
and remodeling of extracellular matrix are still in progress (108).  
The use of pre-degenerated nerve grafts having high matrix 
metalloproteinase (MMP) expression shows some potential as it degrades 
the inhibitory chondroitin sulphate and proteoglycans thereby retaining the 
ability to promote nerve regeneration even in the absence of cells (108, 109).  
Recent advances in nanotechnology (110) and tissue engineering (111, 112) 
have been found to cover a broad range of applications in regenerative 
medicine and offer the most effective strategy to repair neural defects. The 
major determinant in all tissue engineering research is to regulate the cell 
behavior and tissue progression through the development and design of 
synthetic extracellular matrix analogues of novel biomaterials to support 
three-dimensional cell culture and tissue regeneration. Ideal properties of a 
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scaffold for nerve regeneration are biocompatibility, low inflammatory 
potential, controlled biodegradability with non-toxic degradative products, 
porosity for vascularization and cell migration and three-dimensional 
matrices with appropriate mechanical properties to mimic the extracellular 
matrix (113-115).  
Polymeric biomaterials are widely preferred as scaffolds for peripheral and 
central nerve regeneration both in vitro and in vivo (116-119). There is a wide 
choice of polymers available with programmable biodegradability, non- 
toxic/non-inflammatory nature, mechanical properties similar to the tissue to 
be replaced, high porosity that promotes cell attachment and growth, 
economical and simple manufacturing processes along with a potential for 
chemical modification leading to increased interaction with normal tissue 
(120). Several techniques such as nanofiber self-assembly, solvent casting 
and particulate leaching, gas foaming, emulsification/freeze-drying, liquid-
liquid phase separation, electrospinning and computer aided design and 
manufacturing techniques have been employed to fabricate tissue 
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2 AIM OF THE STUDY 
 
The aim of this project was to study the interaction between Schwann cells 
and electrospun scaffolds functionalized with GAGs, purified from aorta 
porcine tissue, to mimic the extracellular matrix. 
As mentioned previously, Schwann cells are the glial cells of PNS that lead the 
process of nerve regeneration by the secretion of trophic support molecules 
and the establishment of a supportive growth matrix. 
To study the behavior of Schwann cells seeded in scaffolds, proliferation 
assays, metabolic activity assays and GAGs assays were performed. 
Immunofluorescence and western blot analysis were carried out using five 
different antibodies: 
Syndecan 1 and Syndecan 4, transmembrane proteoglycans known to bind 
different proteins in ECM, like Fibronectin, Laminin and Collagen; 
Integrin, a transmembrane receptor which forms focal adhesion in 
colocalization with Syndecan 4; 
Laminin, to observe if Schwann cells can be able to produce ECM proteins; 
and p75, also called neurotrophin receptor or low affinity NGF receptors, 
which is a marker of Schwann cells. 
Understanding if GAGs can improve proliferative activities and binding 
capacities  of the cells to the scaffolds could be promising to improve the 
process of nerve regeneration. 
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3 MATERIALS  AND METHODS 
 
 
3.1 PREPARATION OF ELECTROSPUN SCAFFOLDS 
 
Electrospinning is a process that produces a film of fibers by pushing a liquid 
jet through a nozzle with an electric field (125-131). Fiber diameter can range 
from 2 nm to several micrometers by controlling the composition of the 
electrospinning solvent and the identity, degree of chain entanglements, and 
concentration of the starting polymer. Moreover, fiber alignment can be 
manipulated by controlling the motion of the collecting mandrel with respect 
to the source electrospinning suspension.  
Electrospun Polycaprolactone (PCL) fiber mats used as fibrous scaffolds were 
fabricated by electrospinning from a 15% (w/v) PCL solution in 1:4 (v/v) 
Dimethylformamide (DMF) : chloroform. A blunt 20-gauge stainless steel 
hypodermic needle (o.d. ) 0.8 mm was used as the nozzle. A polyurethane 
sheet and an aluminum foil wrapped around a rotating cylinder (cylinder size 
= o.d.  6 cm, length 19 cm ) was used as the collector. The distance from the 
tip of the needle to the surface of the aluminum sheet (measured at a right 
angle to the surface) defining the collection distance was 14 cm. A High-
Voltage power supply was used to generate a direct current potential of 20 
kV. The emitting electrode of positive polarity was connected to the needle, 
while the grounding one was connected to the collector. The feed rate of the 
PCL solution was controlled by syringe pump at 1 mL/h. 
The mandrel speed was regulate around 500 rpm (2.6 V) to obtain scaffolds 
with random fibers, and around 4000 rpm (9 V) to obtain scaffolds with 
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aligned fibers. The needle was set to move back and forth along the length of 
the cylinder to permit an homogeneous fibers deposition on top of the 
polyurethane sheet. 
After continuous spinning for 15 minutes, homogenous PCL fibrous scaffolds 
were obtained. The morphology of the fibrous scaffolds and the size of the 
individual fiber segment therein were examined by a Philips XL30 scanning 
electron microscope. Multiple scanning electron microscopy (SEM) images 
were statistically analyzed using FIJI software, from which the mean value of 




3.2 GLICOSAMINOGLYCANS PURIFICATION 
 
GAGs were purified as described by Naso et al. (132) and Cigliano et al. (133). 
In brief, porcine aortic root from 10-12-month-old pigs were obtained from a 
local slaughterhouse. 
Fatty adherences were removed from aortic tissue by gentle peeling. Wet 
weight of each sample was determined after gently blotting with filter. Aortic 
minced tissues were dehydrated with 20 volumes of acetone at 4°C for 24 h, 
defatted with 20 volumes of chloroform: methanol (2 : 1, v/v) at 4°C for 24 h, 
dried for 24 h at 60◦C after centrifugation at 3300 ×g for 15 minutes, and 
finally weighed (dry-defatted tissue (DDT) weight). DDTs were rehydrated for 
24 h at 4° C in 0.1 M sodium acetate, pH 5.8, containing 5 mM cysteine, and 5 
mM ethylenediaminetetraacetic acid (EDTA) (37 volumes per gram of DDT). 
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Then, papain (0.3U/mg of DDT) was added to the mixture, which was 
incubated at 56° C for 48 h. The digestion was stopped by boiling the solution 
at 100°C for 5 min and then by centrifugation (9000 ×g for 15 min at 4◦ C). 
Digest supernatant was loaded on a diethylaminoethyl (DEAE) Sephacel 
column (1.5 × 50 cm, 70 mL), equilibrated with 50 mM sodium acetate, pH 
6.0. The column was then washed with the same buffer (until reaching Abs280 
< 0.05) and eluted with a one-step salt gradient (1.5 M NaCl). Fractions of 5 
mL were collected and assayed for hexuronate content by the method of 
Bitter and Muir, using glucuronolactone as a standard (134). Fractions 
containing GAGs were pooled and precipitated using 4 volumes of cold 
absolute ethanol. The mixture was left overnight at −20◦C, and the 
precipitate was separated by centrifugation, washed twice with ethanol, and 
then dried. 
The total amount of GAGs was normalized to the fresh/DDT weight to 
estimate the tissue concentrations.  
GAG composition was determined by discontinuous cellulose acetate 
electrophoresis (135). Alcian Blue stained strips were acquired (Gel Doc XR 
System) and analyzed using Quantity One 4.6.3 from BioRad Laboratories. 
Total mass of GAG was determined by reference to established GAG/uronic 
acid weight ratio.  
 
3.3 ELECTROSPUN SCAFFOLDS FUNCTIONALIZATION 
 
A common way of creating a covalent bond is by letting a carboxyl group 
react with a primary amine creating an amide bond, the same bond that links 
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amino acids together in a protein. In vivo, this reaction is brought about by 
the action of many enzymes and other molecules. In vitro, the use of coupling 
reagents is necessary. For example, the carboxyl group is converted to an 
ester by the use of N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide 
hydrochloride (EDC). The ester can then react with the amine to form the 
amide bond. In order to increase the yield of this interaction, N- 
hydroxysuccinimide (NHS) is usually used together with EDC (Fig. 5). It reacts 
with the EDC-ester, protects it from hydrolysis and makes a better leaving 
group for the subsequent reaction. In this case, a surface modification via 
aminolysis of the polyester was followed by functionalization with GAGs. 
Aminolysis of a polyester surface is extremely advantageous as it requires 
only a single step to generate a functional surface. This way would explore 
the use of aminolysis as a one step method in generating functional 
polyesters from which to attach biologically active molecules. 
A commonly used polymer for this aminolysis reaction is PCL because it has 
desirable biocompatibility and biodegradation. This polymer characterized by 
its hydrophobicity, for this reason the aim of the aminolysis reaction is to 
generate a more hydrophilic surface (through the introduction of polar amine 
groups) and increase the compatibility with proliferating cells. 
The most common diamine used in the aminolysis of PCL is 1,6-
hexamethylenediamine (HMDA). 
In the present work PCL scaffolds were first aminolysed and then 
functionalised with GAGs (Fig. 5).  
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Figure 5. Aminolysis and functionalization reactions. 
 
First of all, dried scaffolds were incubate 1 h at 37°C with 5% HMDA in 
isopropanol and then washed three times with water. GAGs purified from 
porcine aorta tissue (100 μgUA solubilized in 100 μL H2O) were added in each 
scaffolds. As negative control scaffolds no functionalized were used; in this 
case 100 μL of water without GAGs were added. A solution of 50 mM 
EDC/NHS in 2-(N-morpholino)ethanesulfonic acid (MES) was added in each 
scaffolds and left over night at room temperature. 
Prior to seeding, no functionalized and functionalized scaffolds (o.d 15 mm) 
were placed into wells of a 24-well non-treated tissue culture plate (VWR). 
Each scaffold was pushed on the bottom of the well with O-rings (Alwin 
Höfert) to prevent cells from migrating out of the scaffolds onto the culture 
plate. Afterwards, supplemented (L- glutamine, FBS, penicillin-streptomycin) 
DMEM media was added in each well and incubated at 37°C with 5.0% CO2 
for 24 h. 
To asses the level of GAG functionalization, an Alcian blue staining protocol 
was developed. In brief, scaffolds were placed in 24-well-plate and stained 
with Alcian blue solution (0.1% Alcian blue, 10 % EtOH, 0.1% CH3COOH, 0.03 
M MgCl2 0.03 M in water) for 30 min at room temperature. Then scaffolds 
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were washed with Alcian blue destaining solution (10 % EtOH, 0.1% 
CH3COOH, 0.03 M MgCl2 0.03 M in water) for 30 min at room temperature. 
To dissolve Alcian blue bound to the GAGs linked to the scaffolds, a solution 
of 1 % SDS was added in each well and left shaking (200 rpm) for 30 min. 
Supernatant was transferred in a new well plate and absorbance (605 nm) 
was read with CLARIOstar plate reader (BMG Labtech). 
 
 
3.4 CELL STUDIES 
 
Neuronal Schwann cells RT4-D6P2T (ATCC® CRL-2768™) were maintained in 
DMEM hight glucose (Thermo Fisher Scientific) supplemented with 2mM L-
glutamine (Thermo Fisher Scientific), 10% fetal bovine serum (FBS; Sigma), 
and penicillin-streptomycin (100 U/mL; Sigma). Cells were removed from the 
culture flasks to seed the scaffolds using a trypsin-EDTA solution (Sigma). 
Viable cell number was determined prior to seeding by live-cell staining using 
0.4% Trypan Blue (Sigma) and counting viable cells with Neubauer chamber.  
The Schwann cell suspension was pipetted onto the surface of the dry 
scaffold (2 x 104 cells/well). The wells were then filled with supplemented (L- 
glutamine, FBS, penicillin-streptomycin) DMEM media until reach the final 
volume of 500 μL, placed into a cell culture incubator, and maintained at 
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3.4.1 CELL METABOLIC STUDIES 
 
To measure the metabolic activity of Schwann cells seeded in scaffolds, 
PrestoBlue® Cell Viability Reagent (Thermo Fisher Scientific) was used. This 
reagent is a cell permeable resazurin-based solution that functions as a cell 
viability indicator by using the reducing power of living cells to quantitatively 
measure the metabolic activity of cells. When added to cells, the reagent is 
modified by the reducing environment of the viable cell and the color turns 
from blue to red, becoming highly fluorescent. 
At the first time point (day 1), 50 µL of 9% Presto Blue in DMEM medium was 
added to each well as the indicator of viable cells. After an incubation at 37°C 
for 30 min, the solution of Presto Blue/DMEM was transferred in a new well 
plate to read the fluorescence using CLARIOstar plate reader. 
The cell cultures were rinsed with PBS and then 500 μL of DMEM medium 
was added in each well. Scaffolds with cells were incubated at 37°C to repeat 
the metabolic assay at day 3 and 7. 
 
3.4.2 DNA ASSAY 
 
To determine the seeding efficiency and cell growth on the scaffolds, DNA 
was quantitated by using a fluorometric DNA assay on cell lysates. 
At every time point, medium was removed and scaffolds with cells were 
rinsed with PBS, dried and transferred in new eppendorfs. Each scaffolds was 
frozen at −80°C for at least 24 h. Then, samples were thawed and the DNA 
content was measured using a CyQuant cell proliferation assay kit 
(Invitrogen) following the manufacturer’s instructions. Samples were 
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incubated with 250 μL of Proteinase K (VWR) digestion buffer (1 mg/mL 
Proteinase K in Tris-EDTA digestion buffer) at 56°C for 16 h. Forty microlitres 
of sample volume were transferred into a black 96-well plate and treated 
with 40 μL/well RNAse for 1 h at room temperature to reassure DNA 
specificity. CyQuant reagent dye was added in a volume of 80 μL, incubated 
for 15 min protected from light at room temperature and fluorescence 
signals (excitation 485 nm, emission 520 nm) detected using CLARIOstar plate 
reader. A standard curve was performed with λDNA, provided with the kit 
and treated equally to the sample plates. The standard ranged from 0.5 
μg/mL to 2 μg/mL λDNA and was used to calculate the final DNA content per 
milliliter of sample.  
 
3.4.3 GAGs QUANTIFICATION 
 
To measure the GAG content in the cells seeded in scaffolds a 
spectrophotometric assays based on 1,9-dimethylmethylene blue (DMMB) 
solution (38 mM DMMB, 9.5 mM HCl, 40.5 mM Glycine, 40.5 mM NaCl in 
water, pH 3). This DMMB solution was stable for at least 4 months when 
stored at room temperature in the darkness.  
To extract GAGs from cells, at 1-3-7 day time points, medium was removed 
and scaffolds with cells were rinsed with PBS and frozen at −20°C for at least 
24 h.  
Samples were incubated with 250 μL of Proteinase K (VWR) digestion buffer 
(1 mg/mL Proteinase K in Tris-EDTA digestion buffer) at 56°C for 16 h. 
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Twenty five microliters of each sample were transferred into a black 96-well 
plate. 2.3 M NaCl (5 μL) and filtered DMMB solution (150 µL) were added in 
each well. The absorbance at 525 nm was directly measured using 
CLARIOstar plate reader. A standard curve was obtained by using a GAG 
standard solution (chondroitin 4- sulfate) dissolved in Proteinase K digestion 
buffer with 10 μg cysteine in 1 mL PBE (0,2 %). The standard ranged from 1 
μg/mL to 10 μg/mL and was used to calculate the final GAG content per 




Schwann cells cultures were fixed for 20 min with 4% paraformaldehyde at 
4°C and rinsed several times with PBS. Cells were permealized with 0.1% 
Triton X-100 (VWR) in PBS for 15 min room temperature and then incubated 
in blocking solution containing 1% bovine serum albumin (BSA, VWR),  5% 
goat serum (Sigma) and 0.05% Tween-20 (VWR) in PBS for 1 hr. In the next 
step, cells were incubated with primary antibody overnight at 4°C. The 
primary antibodies used included rabbit antibody to laminin β2γ1 (1:250, 
Bioconnect), mouse antibody to integrin α9β1 (1:1000, Abcam), mouse 
antibody to syndecan 1 (1:1000 Abcam), and rabbit antibody to syndecan 4 
(1:500, Bioconnect). Cells were washed extensively with 1% BSA, 0.05% 
Tween-20 in PBS and incubated in secondary antibody for 1 h at room 
temperature. As secondary antibodies AlexaFluor-488 goat anti-mouse, and 
AlexaFluor-647 goat anti-rabbit (both 1:500, Invitrogen) were used. For 
visualization of F-actin, cells were incubated with Phalloidin-Alexa Fluor 568 
(5 μL/205 μL in washing buffer, Thermo Fisher Scientific). Nuclei were 
counterstained with 4,6-diamidino-2-phenylindole (DAPI) (5 min at 0.1 
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μg/mL, Sigma).  
Cells were washed extensively with PBS and mounted in Mowiol 4-88 (Sigma) 
at 4°C until imaging. Samples were examined by fluorescence microscopy and 
images were obtained with a Nikon Eclipse Ti2 inverted microscope. Image 
adjustments were limited to contrast enhancement and level settings using 
Nikon software and Fiji (Fiji Is Just ImageJ).  
 
3.4.5 WESTERN BLOT 
 
At each time point, cells were placed on ice immediately following treatment 
and washed with ice-cold PBS. Lysis buffer included cOmplete protease 
inhibitor (Sigma), 2 mM Phenylmethylsulfonyl fluoride (PMSF, Sigma) and 
84.7 % v/v RIPA buffer (Sigma). To minimize the presence of cells debris, 
protein lysate were centrifuged (10000 g) for 10 min at 4°C and supernatant 
was collect and stored at -80°C. For detecting Syndecan 4 neoepitopes, 
protein lysates were pretreated with Heparinase II (2.5 mU/μg protein, 
Sigma) over night at 37 °C. The protein samples were quantified with Pierce 
BCA protein assay kit (Thermo Fisher Scientific) and denatured with equal 
amount of 4X Laemmli Sample buffer (Bio-rad) with 10% 2-mercaptoethanol 
(Sigma) at 100°C for 5 min. For immunodetection, 10 μg of total protein from 
each sample was loaded and separated in 4–15% Mini-PROTEAN TGX Stain-
Free Gel (Bio-Rad) and transferred by electroblotting to PVDF membranes 
(Bio-Rad). The membranes were blocked with 2.6 % Blocking Grade buffer 
(Bio-rad) in TBST (0.1% Tween-20 IN TBS) and incubated overnight at 4 °C in 
the same solution with rabbit antibody to laminin β2γ1 (1:250, Bioconnect), 
mouse antibody to integrin α9β1 (1:500, Abcam), mouse antibody to 
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syndecan 1 (1:250, Abcam), rabbit antibody to syndecan 4 (1:250, 
Bioconnect), rabbit antibody to p75 NGF receptor (1:500 Abcam), and mouse 
antibody to β-actin (1:2500, Sigma). Goat anti-rabbit IgG and Goat anti-
mouse IgG, conjugated with horseradish peroxidase from Bio-rad (1:1500 
dilution), were used as a secondary antibody. For detection, an enhanced 
chemiluminescence Western blot system (ECL, Bio-rad) was used. For 
quantification, the PVDF membranes were visualized using ChemiDoc XRS 
System (Bio-rad). The pictures were analyzed with software Fiji to obtain gray 
value of each band. Then relative gray value of each marker (gray value of 
special marker / gray value of β-actin) were calculated and analyzed. 
 
3.4.6 STATISTICAL ANALYSIS 
 
Each experiment was carried out in triplicate, except western blot 
(quadruplicate). All results are presented as mean – standard deviation (SD). 
GraphPad Prism software v 4.03 (GraphPad, San Diego, CA, USA) was used to 
perform the statistical analysis. Statistical significance was set at a p-value of 
≤ 0.05 (*), ≤ 0.01 (**) or ≤ 0.001 (***).  
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4 RESULTS 
 
4.1 ELECTROSPUN SCAFFOLDS 
 
To determine how the rotation of a grounded mandrel affects scaffold 
structure, the mandrel speed has been set at 500 and 4000 RPM. Under base 
line conditions (mandrel RPM = 500)  PCL solution produced scaffolds 
composed of 1.34 (± 0.23) μm diameter fibers. At 4000 RPM mandrel speed, 
scaffolds were made up of 1.35 (± 0.04) μm diameter fibers. In both cases 
nanofibers had a diameter similar to collagen fibers. 
Fibers produced with different mandrel speed had a rounded cross-sectional 
profile and mandrel RPM did not alter average fiber diameter in scaffolds. 
These data suggested that under specific conditions fiber packing is more 
efficient as mandrel speed was increased, a result that was consistent with 
the induction of increased fiber alignment. The alignment of fiber was a 
crucial point to mimic the pattern of some proteins like collagen and laminin 
in ECM during nerve regeneration. In fact, scaffolds images obtained with 
SEM showed that fibers obtained with a mandrel speed of 4000 RPM were 
aligned compared to the fibers in scaffolds produced at 200 RPM mandrel 
speed. As illustrated in Figure 6, directionality analysis obtained using Fiji 
indicated that the dispersion of fibers was obviously much more consistent in 
scaffolds with random fibers compared to scaffolds with aligned fibers. 
Effectively in this case, as shown in the graph, pixels were concentrated 
almost in the same direction forming a narrow peak. 
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Figure 6. (A) Dispersion average of random and aligned fibers. (B) Analysis of PCL 
scaffolds with random fibers (mandrel speed = 500 rpm). (C) Analysis of PCL 






Glycosaminoglycans purification and caracterization: from pathophysiology to tissue engineering. 
PhD thesis in PhD school in Life Sciences and Biotechnologies, 
Biochemistry, Physiology and Molecular Biology curriculum 
 Università degli studi di Sassari 41 
4.2 GAGs ANALYSIS 
 
As mentioned before, GAGs were purified from porcine vascular tissue. 
Quantitative analysis evidenced GAGs levels corresponding to 3.50 (± 0.08) 
μgUA/mg dry weight and 1.17 (± 0.03) μg UA/mg fresh weight. 
Qualitative analysis showed that GAGs distribution in aortic wall followed this 
trend: 60% Chondroitin sulphate, 20 % Dermatan sulphate, 13% Heparan 
sulphate and 7% Hyaluronic Acid (Fig. 7), as reported by Naso et al. (132).  
 
 












GAGs composition analysis 
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4.3 CROSS-LINKING FUNCTIONALIZATION OF SCAFFOLDS 
 
To evaluate if GAGs purified from aorta porcine tissue were attached to the 
fibers, an Alcian Blue staining protocol was developed. Scaffolds pretreated 
with HMDA had  a percentage of GAG coating increased compared to 
scaffolds hydrolysed with NaOH. PCL scaffolds were activated with 1M NaOH  
for 30 min before the crosslinking reaction described in Materials and 
Methods (p. 28) (Fig. 8) 
 
 
Figure 8. Activation of functionalized PCL scaffolds. Left: scaffolds treated first with 
HMDA followed by a crosslinking reaction without GAGs (HMDA-EDC/NHS), and 
with 100 μg GAGs. Right: scaffolds activated with NaOH to generate carboxylic 
groups in the surface; Absorbance was read in scaffolds without GAGs (NaOH-
EDC/NHS) , with 100 μg, 50 μg, 20 μg of GAGs. (***p < 0.001). 
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Regarding the sterilization of scaffolds, an other experiment was set up to 
verify the efficiency of functionalization correlated with a step of 2h in 70% 
ethanol before or after crosslinking reaction (Fig. 9).  
 
 
Figure 9. Scaffolds sterilization. From left to right: scaffolds were sterilized with 
EtOH before functionalization with GAGs, scaffolds were functionalized without the 
sterilization step, scaffolds were sterilized after crosslinking reaction. The amount of 
GAGs used to functionalized scaffolds was 100 μg. (**p < 0.01) 
 
As shown in fig. 9, functionalization was more efficient when scaffolds were 
not sterilized, or when sterilization step was preceded by crosslinking 
reaction. Since aminolysis reaction takes place in isopropanol, we chose not 
to sterilize scaffolds so avoiding an additional step to the protocol. 
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 In fig. 10 was clearly 
shown how 
functionalization of PCL 
scaffolds with 100 μg of 
GAGs through  
crosslinking  reaction was 
efficient compared to 
functionalization with 
reagents but without 
GAGs, or 
functionalization with 
GAGs but without 
reagents. This result 
highlighted the 
importance of EDC-
NHS reagents in 
crosslinking reaction. Indeed scaffolds subjected to an incubation with GAGs, 
showed a decrease of absorbance compared to scaffolds functionalized with 
the same amount of GAGs and EDC-NHS reagents. 
 
4.4 CELL STUDIES 
 
Preliminary results showed that in cells seeded in scaffolds both metabolic 
and proliferation activities, as well as GAGs production increased per time 
points (Fig. 11).  
Figure 10. PCL scaffolds functionalization through 
crosslinking reaction. Functionalization with EDC-NHS 
reagents (blue column), incubation of 100 μg GAGs 
(yellow column), crosslinking reaction between GAGs 
and PCL fibers due to EDC-NHS reagents. (*p < 0.05) 
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Specifically, Schwann cells showed a decrease of metabolic activities when 
seeded in scaffolds with random fibers functionalized with GAGs, compared 
to cells seeded in no functionalized scaffolds (Fig. 11, A). This phenomenon 
was observed at each time point (day 1-3-7). Regarding cell proliferation 
assay kit (Fig. 11, B), the results showed a significant increase of proliferation 
activities after 7 days of culture in comparison with cells at day 3 time point. 
Moreover, DMMB assay results showed an increase, at each time point, of 
sulfated GAGs in cells seeded in no functionalized and functionalized 
scaffolds. 
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Immunofluorence images showed that Schwann cells seeded in scaffolds with 
aligned fibers had an elongated shape which followed the direction of the 
fibers. On the contrary, cells seeded in scaffolds with random fibers assumed 
a spread structure (Fig 12).  
 
Figure 12. Immunofluorescence images. Nuclei were counterstained with DAPI. F-
actin in red (Phalloidin-Alexa Fluor 568). 
 
Since, immunofluorescence images (Fig. 14-15) showed no differences, 
probably for the presence of the fibers covering the cells seeded, protein 
expression levels were quantified by western blot assays. 
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Figure 13. Immunofluorescence images. Nuclei in blue (DAPI). Upper panel: 
Integrin in green (AlexaFluor-488 goat anti-mouse). Lower panel: Syndecan 4 
in purple (AlexaFluor-647 goat anti-rabbit). 
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Figure 14. Immunofluorescence images. Nuclei in blue (DAPI). Upper panel: 
Syndecan 1 in green (AlexaFluor-488 goat anti-mouse). Lower panel: Laminin 
in purple (AlexaFluor-647 goat anti-rabbit). 
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Integrin, a transmembrane receptor involved in cell-cell and cell-matrix 
interactions, shows  decreased levels from day 1 to day 3 and 7 (Fig. 15). This 
protein is known to be involved in focal adhesion in association with 
Syndecan 4. Interestingly, comparing the trend of protein levels between 
Integrin and Syndecan 4, at day 3 and 7, we observed similar patterns, 
probably due to their colocalization in the plasma membrane. Furthermore, 
at day 7, Schwann cells expressed increased Syndecan 4 levels when seeded 
in functionalized scaffolds with aligned fibers compared to cells seeded in no 
functionalized scaffolds (at the same time point) and cells seeded in 
functionalized scaffolds with aligned fibers at day 3. 
Expression levels of Syndecan 1, a transmembrane proteoglycan implicated in 
the binding to ECM proteins, showed a considerable reduction from day 1 to 
day 3 and 7. 
Laminin showed significantly decreased levels from day 1 to day 7 in cells 
seeded in no functionalized scaffolds with aligned fibers. However, a 
consistent increase of protein expression was observed in Schwann cells 
seeded in no functionalized scaffolds, random and aligned, after 7 days in 
comparison with cells  at day 3. This result suggested that Schwann cells 
started to produce ECM proteins themselves. 
A Schwann cells marker, p75 (or low-affinity nerve growth factor receptor) 
was detected in order to evaluate the involvement of this receptor in cells 
seeded in PCL scaffolds. As shown in Fig. 15, the expression levels of p75 
considerably decreased from day 1 to day 3 and 7, demonstrating a similar 
trend with the others proteins studied. 
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Figure 15. Western blot analysis. (A) Integrin. (B) Syndecan 4. (C) Syndecan 1. (D) 
Laminin. (E) p75. All the values were normalized for β-actin. (*p < 0.05,**p < 0.01). 
 
One of the most important evidence is that at day 7 all the proteins studied 
show increased levels in cells seeded in functionalized scaffolds with aligned 
fibers compared to cells seeded in no functionalized scaffolds with aligned 
fibers. This result could be promising to improve Schwann cells proliferation 
in the “nerve regeneration” after traumatic nerve injury.   
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5 DISCUSSION 
 
Peripheral nerve injuries (PNI) are one of the major clinical problem. In 
general, PNI results from motor vehicle accidents, lacerations with sharp 
objects, penetrating trauma (gunshot wounds) and stretching or crushing 
trauma, and fractures. It is estimated that PNI occur in 2.8% of trauma 
patients and this number reaches 5% if plexus and root lesions are included. 
However, due to lack of recent epidemiological studies, these data probably 
underestimate the actual number of nerve injuries. As mentioned above, 
posttraumatic nerve repair continues to be a major challenge in restorative 
medicine and microsurgery. Although progress has been made in surgical 
techniques over the last 30 years, functional recovery after a severe lesion of 
a major nerve trunk is often incomplete and often unsatisfactory. Functional 
recovery after surgical repair of mixed nerves is even more disappointing. 
Compared to the central nervous system, peripheral axons have the ability to 
regenerate. It is known since Ramón y Cajal (1928) report that axonal 
elongation over long distances requires considerable assistance by Schwann 
cells. In neural development, axons extend to their appropriate terminal 
organs accompanied by Schwann cells. In axonal regeneration after a 
peripheral nerve injury, Schwann cells proliferate in the distal part of the 
transected nerve, where they form the bands of Büngner after Wallerian 
degeneration (136), and also stimulate the elongation of regenerating axons 
over longer distances by secreting neurotrophins, such as nerve growth 
factor (137), which are transported to the neural cell body (138).  
Several animal studies have shown that prompt reinnervation of the end 
organ is the main determinant of a satisfactory functional recovery. It is well 
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known that in human clinical set there is a delay in repairing an injured nerve 
and this delay can cause changes that make nerve fibers unable to 
regenerate, and the muscles undergo atrophy and lose the ability to be 
reinnervated (139).Taking into account these data, researchers are constantly 
trying to develop strategies to increase the therapeutic success rate of 
regeneration and functional recovery.  
Biotechnology and tissue engineering represent a multidisciplinary approach 
to solving some of the most demanding medical problems, particularly the 
creation of new tissues similar to those in the living organism. These new 
technical approaches include strategies in using new synthetic polymer 
formulations, biological constructs as well as various alternatives in tissue 
regeneration. Fundamental issues in tissue engineering include scaffold 
formation, cell cultures and cell signals.  
In this PhD project, Electrospun PCL scaffolds were produced using a mandrel 
in which were applied two different speeds to obtain two types of scaffolds: 
with random fibers and with aligned fibers. The strategy was focused to 
mimic the pattern of some proteins like collagen and laminin in ECM during 
nerve regeneration. In both cases nanofibers have a diameter around 1.3 um, 
a fiber diameter similar to collagen fibers. 
To support Schwann cells growth in a polymeric support, scaffolds were 
functionalized through a cross-linking reaction which allows GAGs to be 
bound to the fibers. The GAG molecules are long unbranched polysaccharides 
containing a repeating disaccharide unit. Except for hyaluronic acid, GAGs are 
highly negatively charged molecules, with extended conformation that 
imparts high viscosity to the solution in which they reside. GAGs are located 
primarily on the surface of cells or in the ECM but are also found in secretory 
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vesicles in some types of cells. However, the majority of GAGs in the body are 
linked to core proteins, forming proteoglycans. Many forms of proteoglycans 
are present in virtually all extracellular matrices of connective tissues. The 
major biological function of proteoglycans derives from the physicochemical 
characteristics of their glycosaminoglycan component, which provides 
hydration and swelling pressure to the tissue enabling it to withstand 
compressional forces. In addition to their hydrodynamic functions, 
proteoglycans have distinct biological functions, and their involvement in 
many aspects of cell and tissue activities has been demonstrated. For 
example, Syndecans, a family of high sulfated transmembrane proteoglycans, 
are implicated in the binding to ECM proteins. As a matter of fact, specific 
interactions between proteoglycans (through both their glycosaminoglycan 
and core protein moieties) and macromolecules in the extracellular matrix 
are key factors in the functional roles of proteoglycans. 
To evaluate the role of GAGs and proteoglycans in nerve regeneration,  
Schwann cells were seeded in functionalized and no functionalized scaffolds 
with random and aligned fibers. Metabolic activity assays, proliferation 
assays and GAGs assays were executed. Immunofluorescence and western 
blot were performed using five different antibodies. Syndecan 1, a 
transmembrane proteoglycan, is known to be involved in cytoscheletal 
reorganization and in attachment of cells to ECM. On the other hand, 
Syndecan 4 is known to bind different proteins in ECM and also to be 
involved in promoting focal adhesion in co-localization with Integrins, a 
transmembrane receptor. In addition, we evaluated the expression levels of 
p75, a marker of differentiation in Schwann cells, and Laminin, an ECM 
protein, to observe if Schwann cells can be able to produce Laminin 
themselves. 
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Results show that in cells seeded in scaffolds both metabolic and 
proliferation activities, as well as GAGs production increase per time points. 
Since images obtained by immunofluorescence were not very clear due to 
the presence of the scaffold, the levels of protein expression were evaluated 
by western blot assays. Except for Syndecan 4, all the proteins show a general 
decrease of expression level from day 1 to day 3 and day 7. Moreover at day 
7 all the proteins studied reveal increased levels in cells seeded in 
functionalized scaffolds with aligned fibers compared to cells seeded in the 
same kind of scaffolds. 
These results suggest that Schwann cells are metabolically active and able to 
proliferate in PCL electrospun scaffolds following functionalization with GAGs 
to create an extracellular environment similar to the natural Schwann cell 
basal lamina.  
In conclusion, PCL–GAG scaffolds could represent a promising artificial 
substrate that closely mimics the recently established pattern of Schwann 
cells migration into the regenerating nerve. 
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